Topamax and Birth Defects: Trial opens in Philadelphia

Janssen’s Topamax Users blame Drug for Birth Defects

Janssen's Topamax Users Blame Drug for Birth Defects
Bloomberg News is the first word in business and finance

Johnson & Johnson’s (JNJ) Janssen Pharmaceuticals failed to inform expectant mothers of risks that its epilepsy drug Topamax could cause birth defects, a lawyer for the mother of a Virginia 6-year-old told a jury. April Czimmer wouldn’t have taken Topamax for more than six months had she known the risks associated with the drug, her attorney Tommy Fibich said in opening statements today in state court in Philadelphia. Czimmer blames the drug for her son’s cleft palate and lip and claims Janssen negligently failed to inform patients about its risks until the U.S. Food and Drug Administration ordered stronger warnings in 2011. ”

Continue reading Janssen’s Topamax Users Blame Drug for Birth Defects, by Sophia Pearson, Bloomberg, 15 Oct 2013

All our posts tagged AEDsTopamaxTopiramateValproate

6 thoughts on “Topamax and Birth Defects: Trial opens in Philadelphia”

Have your say ! Share your views